Machine Learning Layers in Google’s AI Strategy
In this episode, we discuss the machine learning layers within Google’s AI strategy as introduced at Cloud Next. Discover how these advancements impact the larger AI ecosystem. See Privacy Policy at ...
22 Huhti 16min
New Apple CEO, OpenAI's New Image Model, Vercel AI Hack
In this episode, we explore the significant leadership change at Apple as Tim Cook steps down and John Tarnas takes the helm, amid ongoing challenges in the AI sector. We also discuss major developmen...
21 Huhti 16min
Anthropic's Revenue Gains Over OpenAI Explored
In this episode, we analyze Anthropic's recent revenue success compared to OpenAI. Explore the changing dynamics in the AI model landscape. See Privacy Policy at https://art19.com/privacy and Califor...
20 Huhti 14min
OpenAI's Codex: What’s New and Exciting
In this episode, we discuss what's new and exciting about OpenAI's Codex. Explore the enhancements that could change AI utilization. See Privacy Policy at https://art19.com/privacy and California Pri...
17 Huhti 14min
Anthropic Ships Opus 4.7, $2B With No Product & Google AI Deals
Anthropic dropped Claude Opus 4.7 today, but the bigger story is the model they didn't release. We break down Project Glasswing, why Mythos stays locked up, and what it signals about where frontier AI...
16 Huhti 14min
Anthropic's IPO Play, Novo Nordisk x OpenAI, and the First Brain Sensor Goes Human
Anthropic adds the Novartis CEO to its board as it gears up for an IPO — and on the same day, Novo Nordisk partners with OpenAI to supercharge drug development. We break down what this healthcare AI l...
15 Huhti 15min
Altman Gets Molotov Cocktail, Zuckerberg Creates AI Clone
In this episode, we explore groundbreaking developments in the tech world, including Mark Zuckerberg's creation of an AI version of himself and Apple's revolutionary smart glasses. We also discuss the...
13 Huhti 15min
Meta's New Model, Gemini 4, OpenAI Proposes AI Policy
Today we (really just me lol) talk about Google's launch of Gemini 4, a groundbreaking open-source model. We also discuss the implications of Eli Lilly's powerful new supercomputer for drug developmen...
9 Huhti 15min
